# US 2010/0145670 A1 · System and method for managing type 2 diabetes mellitus through a personal predictive management tool

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0145670 A1
- Document ID: US20100145670A1
- Status: Published application
- Kind: A1
- Application number: 12/030,130
- Filed: 2008-02-12
- Published: 2010-06-10
- Earliest claimed: 2008-02-12
- Inventors: Clifton A. Alferness; Gust H. Hardy
- Web page: https://patentgrep.com/patent/US20100145670A1

## CPC

- G16H 50/50: for simulation or modelling of medical disorders
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 20/60: relating to nutrition control, e.g. diets
- G16Z 99/00: Subject matter not provided for in other main groups of this subclass
- G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 70/60: relating to pathologies
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16Z: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR

## Abstract

A system and method for managing Type 2 diabetes mellitus through a personal predictive management tool is provided. An insulin resistance for a Type 2 diabetes patient is identified. A time course curve is maintained for a patient population including expected blood glucose levels for a type of human-consumable food. The blood glucose levels following consumption of the food is estimated by adjusting the time course curve as a function of the patient-specific insulin resistance that has been manifested.

## Claims

### Claim 1

A system for managing Type 2 diabetes mellitus through a personal predictive management tool, comprising:
a database comprising:
an insulin resistance for a Type 2 diabetes patient; and
a time course curve for a patient population comprising expected blood glucose levels for a type of human-consumable food; and
an analysis module configured to estimate the blood glucose levels following consumption of the food by adjusting the time course curve as a function of the patient-specific insulin resistance that has been manifested.

### Claim 2 (depends on 1)

A system according to claim 1, further comprising:
an analysis module configured to determine an effect on the insulin resistance for a physical activity, wherein the time course curve is revised based on the effect of the physical activity.

### Claim 3 (depends on 1)

A system according to claim 1, further comprising:
an analysis module configured to determine an effect on the insulin resistance for an antidiabetic medication, wherein the time course curve is revised based on the effect of the antidiabetic medication.

### Claim 4 (depends on 1)

A system according to claim 1, further comprising:
a personal insulin response profile for the patient for a type of insulin preparation further comprised in the database, wherein the blood glucose levels following consumption of the food are estimated by evaluating an interaction between the personal insulin response profile and the time course curve over a duration of action of the insulin preparation.

### Claim 5 (depends on 1)

A system according to claim 1, further comprising:
a library of time course curves for a multiplicity of types of human-consumable foods for a patient population, wherein the time course curves are aggregated from a common reference time, and the estimated blood glucose levels are revised as a function of the aggregated time course curves.

### Claim 6 (depends on 1)

A system according to claim 1, further comprising:
a library of insulin response profiles for the patient for other types of insulin preparations for Type 2 diabetes mellitus treatment, wherein the personal insulin response profiles for each of the other types of insulin preparation are referenced.

### Claim 7 (depends on 1)

A system according to claim 1, further comprising:
a blood glucose level threshold; and
a forecasting module configured to identify a point at which an expected blood glucose level from the personal insulin response profile is expected to either exceed or fall below the blood glucose level threshold.

### Claim 8 (depends on 1)

A system according to claim 1, further comprising:
a carbohydrate sensitivity for the patient;
a blood glucose estimator module configured to generate a personal time course curve for the patient, comprising:
a modeling module configured to determine a carbohydrate sensitivity coefficient by interpolating the carbohydrate sensitivity over the patient population time course curve; and
an application module configured to apply the carbohydrate sensitivity coefficient to the patient population time course curve.

### Claim 9 (depends on 1)

A system according to claim 1, wherein the time course curve is provided as a projection of one of a glycemic index and glycemic load for the type of food.

### Claim 10 (depends on 1)

A system according to claim 1, wherein an empirically observed increase in blood glucose level is identified for a fixed-sized serving of the type of food as the carbohydrate sensitivity.

### Claim 11 (depends on 10)

A system according to claim 10, wherein the empirically observed rise during discrete time intervals is determined throughout a 24-hour period.

### Claim 12 (depends on 1)

A system according to claim 1, further comprising:
an insulin estimator configured to determine parameters for a dosage of the insulin preparation, and to re-evaluate the insulin sensitivity coefficient by applying the parameters to the personal insulin response profile.

### Claim 13 (depends on 12)

A system according to claim 12, wherein the dosage parameters comprises one or more of insulin basal dose, insulin bolus dose, insulin bolus timing, period of day, and time of day.

### Claim 14 (depends on 1)

A system according to claim 1, further comprising:
an evaluation module configured to determine factors affecting the patient, and to re-estimate the blood glucose levels applying the patient factors to the time course curve.

### Claim 15 (depends on 14)

A system according to claim 14, wherein the patient factors comprises one or more of timing of consumption, amount of food, food composition, patient activity level, patient activity timing, and patient physical condition.

### Claim 16 (depends on 1)

A system according to claim 1, wherein the personal insulin response profile is characterized by timing of onset, peak of action, and duration of action of the insulin preparation.

### Claim 17 (depends on 1)

A system according to claim 1, wherein the insulin preparation type comprises one of rapid-acting insulin, short-acting insulin, intermediate-acting insulin, long-acting insulin, insulin glargine, insulin detemir, and an insulin preparation combination.

### Claim 18

A method for managing Type 2 diabetes mellitus through a personal predictive management tool, comprising:
identifying an insulin resistance for a Type 2 diabetes patient;
maintaining a time course curve for a patient population comprising expected blood glucose levels for a type of human-consumable food; and
estimating the blood glucose levels following consumption of the food by adjusting the time course curve as a function of the patient-specific insulin resistance that has been manifested.

### Claim 19 (depends on 18)

A method according to claim 18, further comprising:
determining an effect on the insulin resistance for a physical activity; and
revising the time course curve based on the affect of the physical activity.

### Claim 20 (depends on 18)

A method according to claim 18, further comprising:
determining, an effect on the insulin resistance for an antidiabetic medication; and
revising the time course curve based on the effect of the antidiabetic medication.

### Claim 21 (depends on 18)

A method according to claim 18, further comprising:
referencing a personal insulin response profile for the patient for a type of insulin preparation; and
estimating the blood glucose levels following consumption of the food by evaluating an interaction between the personal insulin response profile and the time course curve over a duration of action of the insulin preparation.

### Claim 22 (depends on 18)

A method according to claim 18, further comprising:
assembling a library of time course curves for a multiplicity of types of human-consumable foods for a patient population;
aggregating the time course curves from a common reference time; and
revising the estimated blood glucose levels as a function of the aggregated time course curves.

### Claim 23 (depends on 18)

A method according to claim 18, further comprising:
assembling a library of insulin response profiles for the patient for other types of insulin preparations for Type 2 diabetes mellitus treatment; and
referencing the personal insulin response profiles for each of the other types of insulin preparation.

### Claim 24 (depends on 18)

A method according to claim 18, further comprising:
defining a blood glucose level threshold; and
identifying a point at which an expected blood glucose level from the personal insulin response profile is expected to either exceed or fall below the blood glucose level threshold.

### Claim 25 (depends on 18)

A method according to claim 18, further comprising:
obtaining a carbohydrate sensitivity for the patient;
generating a personal time course curve for the patient, comprising:
determining a carbohydrate sensitivity coefficient by interpolating the carbohydrate sensitivity over the patient population time course curve; and
applying the carbohydrate sensitivity coefficient to the patient population time course curve.

### Claim 26 (depends on 18)

A method according to claim 18, further comprising:
providing the time course curve as a projection of one of a glycemic index and glycemic load for the type of food.

### Claim 27 (depends on 18)

A method according to claim 18, further comprising:
identifying an empirically observed increase in blood glucose level for a fixed-sized serving of the type of food as the carbohydrate sensitivity.

### Claim 28 (depends on 27)

A method according to claim 27, further comprising:
determining the empirically observed rise during discrete time intervals throughout a 24-hour period.

### Claim 29 (depends on 18)

A method according to claim 18, further comprising:
determining parameters for a dosage of the insulin preparation; and
re-evaluating the insulin sensitivity coefficient by applying the parameters to the personal insulin response profile.

### Claim 30 (depends on 29)

A method according to claim 29, wherein the dosage parameters comprises one or more of insulin basal dose, insulin bolus dose, insulin bolus timing, period of day, and time of day.

### Claim 31 (depends on 18)

A method according to claim 18, further comprising:
determining factors affecting the patient; and
re-estimating the blood glucose levels applying the patient factors to the time course curve.

### Claim 32 (depends on 31)

A method according to claim 31, wherein the patient factors comprises one or more of timing of consumption, amount of food, food composition, patient activity level, patient activity timing, and patient physical condition.

### Claim 33 (depends on 18)

A method according to claim 18, wherein the personal insulin response profile is characterized by timing of onset, peak of action, and duration of action of the insulin preparation.

### Claim 34 (depends on 18)

A method according to claim 18, wherein the insulin preparation type comprises one of rapid-acting insulin, short-acting insulin, intermediate-acting insulin, long-acting insulin, insulin glargine, insulin detemir, and an insulin preparation combination.
